Caseware UK (AP4) 2024.0.164 2024.0.164 2024-04-302024-04-302023-02-14falseprescription dispensing services4truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14662442 2023-02-13 14662442 2023-02-14 2024-04-30 14662442 2022-05-01 2023-02-13 14662442 2024-04-30 14662442 c:Director1 2023-02-14 2024-04-30 14662442 d:PlantMachinery 2023-02-14 2024-04-30 14662442 d:PlantMachinery 2024-04-30 14662442 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-02-14 2024-04-30 14662442 d:FurnitureFittings 2023-02-14 2024-04-30 14662442 d:FurnitureFittings 2024-04-30 14662442 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-02-14 2024-04-30 14662442 d:ComputerEquipment 2023-02-14 2024-04-30 14662442 d:ComputerEquipment 2024-04-30 14662442 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-02-14 2024-04-30 14662442 d:OwnedOrFreeholdAssets 2023-02-14 2024-04-30 14662442 d:CurrentFinancialInstruments 2024-04-30 14662442 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 14662442 d:ShareCapital 2024-04-30 14662442 d:RetainedEarningsAccumulatedLosses 2024-04-30 14662442 c:FRS102 2023-02-14 2024-04-30 14662442 c:AuditExemptWithAccountantsReport 2023-02-14 2024-04-30 14662442 c:FullAccounts 2023-02-14 2024-04-30 14662442 c:PrivateLimitedCompanyLtd 2023-02-14 2024-04-30 14662442 e:PoundSterling 2023-02-14 2024-04-30 iso4217:GBP xbrli:pure

Registered number: 14662442










MANSFIELD HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 30 APRIL 2024

 
MANSFIELD HEALTHCARE LIMITED
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OFMANSFIELD HEALTHCARE LIMITED
FOR THE PERIOD ENDED 30 APRIL 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Mansfield Healthcare Limited for the period ended 30 April 2024 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

This report is made solely to the director of Mansfield Healthcare Limited in accordance with the terms of our agreement. Our work has been undertaken solely to prepare for your approval the financial statements of Mansfield Healthcare Limited and state those matters that we have agreed to state to him in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mansfield Healthcare Limited and its  director for our work or for this report.
 
 
It is your duty to ensure that Mansfield Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the Company's assets, liabilities, financial position and profit. You consider that Mansfield Healthcare Limited is exempt from the statutory audit requirement for the period.
 
 
We have not been instructed to carry out an audit or review of the financial statements of Mansfield Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.







Shipleys Tax Planning
 

14 February 2025
Page 1

 
MANSFIELD HEALTHCARE LIMITED
REGISTERED NUMBER: 14662442

BALANCE SHEET
AS AT 30 APRIL 2024

2024
Note
£

Fixed assets
  

Tangible assets
  
9,429

  
9,429

Current assets
  

Stocks
  
35,000

Debtors: amounts falling due within one year
  
448,340

Cash at bank and in hand
  
70,790

  
554,130

Creditors: amounts falling due within one year
  
(394,549)

Net current assets
  
 
 
159,581

Total assets less current liabilities
  
169,010

  

Net assets
  
169,010


Capital and reserves
  

Called up share capital 
  
106

Profit and loss account
  
168,904

  
169,010


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 February 2025.






Page 2

 
MANSFIELD HEALTHCARE LIMITED
REGISTERED NUMBER: 14662442

BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2024

Raza Ali
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
MANSFIELD HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2024

1.


General information

Mansfield Healthcare Limited is a company domiciled in England & Wales, registration number
14662442. The registered office is 8 Norman Avenue, Sunnyhill, Derby, England, DE23 1HL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Page 4

 
MANSFIELD HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
Fixtures and fittings
-
25%
Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
MANSFIELD HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

14 months ended
30 April
2024
£

Wages and salaries
7,438

Social security costs
2,011

9,449


The average monthly number of employees, including directors, during the period was 4.

Page 6

 
MANSFIELD HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2024

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£



Cost or valuation


Additions
1,250
7,312
4,512
13,074



At 30 April 2024

1,250
7,312
4,512
13,074



Depreciation


Charge for the period on owned assets
313
1,828
1,504
3,645



At 30 April 2024

313
1,828
1,504
3,645



Net book value



At 30 April 2024
937
5,484
3,008
9,429


5.


Debtors

2024
£


Trade debtors
133,561

Other debtors
314,779

448,340



6.


Cash and cash equivalents

2024
£

Cash at bank and in hand
70,790

70,790


Page 7

 
MANSFIELD HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2024

7.


Creditors: Amounts falling due within one year

2024
£

Trade creditors
55,731

Corporation tax
49,936

Other taxation and social security
2,011

Other creditors
219,438

Accruals and deferred income
67,433

394,549



8.


Related party transactions

During the period Firstcare (Mansfield) Ltd (a subsidary) loaned the company £200,000. At the balance sheet date other creditors included £200,00 as amounts owed to Firstcare Mansfield.
During the period the company loaned Firstcare Newgate 2 Ltd (a subsidary) £257,253. At the balance sheet date other debtors included £257,253 as amounts owed from Firstcare Newgate 2 Ltd.
Dring the period Firstcare (UK) Ltd (a subsidary) loaned the company £12,000. At the balance sheet date other creditors included £12,000 as amounts owed to Firstcare (UK) Ltd. 
During the period the company loaned Firstcare Consultants Ltd (a company owned by the director) £3,000. At the balance sheet date other debtors included £3,000 asamounts owed from Firstcare Consultants Ltd.


9.


Controlling party

The company is ultimately controlled by the director Raza Ali.


Page 8